Cardlytics, Inc.
CDLX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -17.7% | 2.2% | -16.4% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 46.7% | 46.3% | 40.6% | 44.2% |
| EBITDA | -$0 | $0 | -$0 | -$0 |
| % Margin | -121.6% | 0% | -6.4% | -9.1% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -139.7% | -14.7% | -21.5% | -21.1% |
| EPS Diluted | -1.36 | -0.18 | -0.26 | -0.31 |
| % Growth | -655.6% | 30.8% | 16.1% | – |
| Operating Cash Flow | $0 | $0 | -$0 | $0 |
| Capital Expenditures | -$0 | $0 | $0 | -$0 |
| Free Cash Flow | -$0 | $0 | -$0 | -$0 |